Filing Details

Accession Number:
0001209191-21-007724
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-04 16:19:15
Reporting Period:
2021-02-03
Accepted Time:
2021-02-04 16:19:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
708818 Nextgen Healthcare Inc. NXGN Services-Computer Integrated Systems Design (7373) 952888568
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813060 David Ahmadzai 3525 Piedmont Rd., Ne
Building 6, Suite 700
Atlanta GA 30305
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-03 3,250 $16.37 36,952 No 4 M Direct
Common Stock Acquisiton 2021-02-03 1,500 $16.64 38,452 No 4 M Direct
Common Stock Acquisiton 2021-02-03 3,000 $16.83 41,452 No 4 M Direct
Common Stock Disposition 2021-02-03 10,446 $19.61 31,006 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock option (right to buy) Disposition 2021-02-03 3,250 $0.00 3,250 $16.37
Common Stock Non-Qualified Stock option (right to buy) Disposition 2021-02-03 1,500 $0.00 1,500 $16.64
Common Stock Non-Qualified Stock option (right to buy) Disposition 2021-02-03 3,000 $0.00 3,000 $16.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,250 2025-06-13 No 4 M Direct
0 2023-05-22 No 4 M Direct
6,000 2026-06-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.5801 to $19.67, inclusive. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
  2. Options exercised vested on June 13, 2020. Remaining options reported in column 9 will vest on June 13, 2021.
  3. Options exercised vested on May 22, 2020.
  4. Options exercised vested on June 1, 2020. Remaining options reported in column 9 will vest on June 1, 2021 and June 1, 2022.